Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases. [electronic resource]
Producer: 20190705Description: 1187-1194 p. digitalISSN:- 1432-0851
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Bone Neoplasms -- drug therapy
- Denosumab -- pharmacology
- Female
- Humans
- Ipilimumab -- pharmacology
- Kaplan-Meier Estimate
- Male
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab -- pharmacology
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Progression-Free Survival
- RANK Ligand -- antagonists & inhibitors
- Retrospective Studies
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.